Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6137)
All Articles published online
|
Publishing Process of This Article
|
Nov 4, 2013 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Critical Care Medicine
ISSN
2220-3141
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55 [PMID: 24701416 DOI: 10.5492/wjccm.v2.i4.48] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm |
| Number | Citing Articles |
| 1 |
Shikun Jiang, Annoor Awadasseid, Suresh Narva, Song Cao, Yoshimasa Tanaka, Yanling Wu, Wei Fu, Xiaoyin Zhao, Chuanhe Wei, Wen Zhang. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure. Life Sciences 2020; 258: 118252 doi: 10.1016/j.lfs.2020.118252
|
| 2 |
L. V. K. S. Bhaskar, L. Saikrishna. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 191 doi: 10.1007/978-981-13-1486-5_14
|
| 3 |
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto, Kazuo Shirouzu. Molecular targeting to treat gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13741-13755 doi: 10.3748/wjg.v20.i38.13741
|
| 4 |
Isabella Monia Montagner, Anna Merlo, Gaia Zuccolotto, Davide Renier, Monica Campisi, Gianfranco Pasut, Paola Zanovello, Antonio Rosato, Irina V. Lebedeva. Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs. PLoS ONE 2014; 9(11): e112240 doi: 10.1371/journal.pone.0112240
|
| 5 |
Marwa Matboli, Sarah El-Nakeep, Nourhan Hossam, Alaa Habieb, Ahmed E M Azazy, Ali E Ebrahim, Ziad Nagy, Omar Abdel-Rahman. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World Journal of Gastroenterology 2016; 22(26): 5896-5908 doi: 10.3748/wjg.v22.i26.5896
|
| 6 |
Xiaoxun Wang, Xiaofang Che, Yang Yu, Yu Cheng, Ming Bai, Zichang Yang, Qiqiang Guo, Xiaochen Xie, Danni Li, Min Guo, Kezuo Hou, Wendong Guo, Xiujuan Qu, Liu Cao. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01703-x
|
| 7 |
Simona Gurzu, Zoltan Kadar, Haruhiko Sugimura, Tivadar Bara, Tivadar Bara, Ioana Halmaciu, Ioan Jung. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS 2015; 123(3): 223 doi: 10.1111/apm.12347
|
| 8 |
Long Bai, Feng Wang, Zhe-zhen Li, Chao Ren, Dong-sheng Zhang, Qi Zhao, Yun-xin Lu, De-shen Wang, Huai-qiang Ju, Miao-zhen Qiu, Zhi-qiang Wang, Feng-hua Wang, Rui-hua Xu. Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine 2016; 95(51): e4531 doi: 10.1097/MD.0000000000004531
|
| 9 |
Yalei Lv, Lina Song, Liang Chang, Xiaolin Zhang, Yan Liu, Wei Liu. Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S190 doi: 10.4103/0973-1482.171364
|
| 10 |
Fiorella Tesan, Cristal Cerqueira-Coutinho, Jimena Salgueiro, Marta de Souza Albernaz, Suyenne Rocha Pinto, Sara Rhaissa Rezende Dos Reis, Emerson Soares Bernardes, Diego Chiapetta, Marcela Zubillaga, Ralph Santos-Oliveira. Characterization and biodistribution of bevacizumab TPGS-based nanomicelles: Preliminary studies. Journal of Drug Delivery Science and Technology 2016; 36: 95 doi: 10.1016/j.jddst.2016.09.011
|
| 11 |
Jui‐Feng Hsu, Yen‐Lung Lee, Hsu‐Liang Chang, Po‐Ju Wei, Yu‐Ting Shen, Chi‐Min Lin, Ching‐Yi Li, Inn‐Wen Chong, Chih‐Jen Yang. Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung. Asia-Pacific Journal of Clinical Oncology 2019; 15(5) doi: 10.1111/ajco.13131
|
| 12 |
Tong Zhu, Xueqian Hu, Pinkang Wei, Guangzhi Shan. Molecular background of the regional lymph node metastasis of gastric cancer (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.7813
|